在澳大利亚的背景下,癌症发病率和结果登记:系统性审查
Kit Chong1,2, Jack Maida1,2, Hwa Ian Ong1,2
1Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.
ANZ journal of surgery
|September 5, 2023
概括
澳大利亚的癌症登记处跟踪发病率和结果. 本综述比较了癌症结果注册表 (COR) 和癌症发病率注册表 (CIR),突出了数据挑战和改善癌症研究的合作需求.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗信息学 医疗信息学
背景情况:
- 癌症登记册对于监测澳大利亚的癌症发病率和治疗结果至关重要.
- 现有注册表的类型各不相同,为加强协作和数据链接提供了潜力.
- 需要对澳大利亚癌症注册表类型和景观进行批判性审查.
研究的目的:
- 对澳大利亚的癌症注册表类型进行批判性审查.
- 为了评估澳大利亚癌症注册地图.
- 确定合作和数据链接的领域.
主要方法:
- 在2022年9月之前对MEDLINE,EMBASE和Cochrane图书馆进行系统审查.
- 纳入标准集中在澳大利亚/新西兰的注册,结果,发病率和链接的数据库.
- 对澳大利亚的癌症登记处进行灰色文献搜索;提取基础设施细节进行比较.
主要成果:
- 12篇文章符合3,216个确定中的包含标准;28个注册表通过灰色文献找到.
- 癌症结果注册表 (COR) 和癌症发病率注册表 (CIR) 的比较揭示了不同的优缺点.
- 数据链接为癌症研究提供了好处,但面临着实施挑战;不同的管理影响着注册表的准确性和完整性.
结论:
- 结果注册提供了详细信息,但覆盖范围不完整; 发病率注册记录了大量数据集,但不准确.
- 改善结果注册表中的数据覆盖率和发生率注册表中的数据质量保证是至关重要的.
- 在定义结果,数据链接和后勤规划方面的合作可以提高临床效用.
关键词:
癌症发生率 癌症发生率癌症结局登记处 癌症结局登记处数据收集数据收集数据收集数据链接数据链接我们的数据库数据库数据库数据库.登记 登记 登记 登记 登记登记处 登记处 登记处 登记处注册表基础设施的基础设施注册表基础设施.更多相关视频
相关概念视频
01:21Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
01:25Statistical Methods for Analyzing Epidemiological Data
408
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
408
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
01:08Prevalence and Incidence
623
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
623
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
01:20Actuarial Approach
96
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
96